Lead Product(s) : Urolithin A
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Mprex Healthcare Pvt. Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioavailability of Seven Mitopure Formulations
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
February 28, 2025
Lead Product(s) : Urolithin A
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Mprex Healthcare Pvt. Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Urolithin A
Therapeutic Area : Musculoskeletal
Study Phase : Undisclosed
Sponsor : Université du Québec a Montréal | McGill University Health Centre Research Institute
Deal Size : Inapplicable
Deal Type : Inapplicable
Impact of Urolithin A (Mitopure) on Mitochondrial Quality in Muscle of Frail Older Adults
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
August 16, 2024
Lead Product(s) : Urolithin A
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Sponsor : Université du Québec a Montréal | McGill University Health Centre Research Institute
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Urolithin A
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Mprex Healthcare Pvt. Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioavailability of Five Mitopure Formulations
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
April 12, 2024
Lead Product(s) : Urolithin A
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Mprex Healthcare Pvt. Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Urolithin A
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase II
Sponsor : Amazentis
Deal Size : Inapplicable
Deal Type : Inapplicable
Oral Supplementation During PR Participation in COPD
Details : Undisclosed
Product Name : Mitopure
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
March 21, 2024
Lead Product(s) : Urolithin A
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase II
Sponsor : Amazentis
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Urolithin A
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Sponsor : Goethe University
Deal Size : Inapplicable
Deal Type : Inapplicable
Urolithin A Supplementation to Boost Immune Health
Details : Undisclosed
Product Name : Mitopure
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
February 21, 2023
Lead Product(s) : Urolithin A
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Sponsor : Goethe University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Urolithin A
Therapeutic Area : Musculoskeletal
Study Phase : Preclinical
Sponsor : Scripps Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Mitopure® is a highly pure form of Urolithin A; a bioactive dietary metabolite that is produced by gut bacteria after eating certain foods, such as the pomegranate, though it is difficult for most people to get enough of this specialized nutrient from f...
Product Name : Mitopure
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
July 07, 2022
Lead Product(s) : Urolithin A
Therapeutic Area : Musculoskeletal
Highest Development Status : Preclinical
Sponsor : Scripps Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Urolithin A
Therapeutic Area : Musculoskeletal
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : New research by scientists in Switzerland shows supplementation with Mitopure (Urolithin A) had exercise-like effects on muscle strength after 4-months (+12%), published in Cell Reports Medicine.
Product Name : Mitopure
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
May 17, 2022
Lead Product(s) : Urolithin A
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Urolithin A
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
August 02, 2021
Lead Product(s) : Urolithin A
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Urolithin A
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Atlantia Food Clinical Trials
Deal Size : Inapplicable
Deal Type : Inapplicable
Mitopureâ„¢ (Proprietary Urolithin A) Bioavailability in Healthy Adults
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
November 13, 2019
Lead Product(s) : Urolithin A
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Atlantia Food Clinical Trials
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Urolithin A
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase I
Sponsor : Eurofins CDMO
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
January 14, 2016
Lead Product(s) : Urolithin A
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase I
Sponsor : Eurofins CDMO
Deal Size : Inapplicable
Deal Type : Inapplicable